References
1. Zhang K, Zhang W, Xia F, Wang N, Lu Y, Sui C, et
al. Obesity Patterns, Metabolic Abnormality, and
Diabetic Kidney Disease in Patients with Type 2
Diabetes. Diabetes Metab Syndr Obes. 2023;16:3999-
4011.
2. Schumann T, Onig JK, Henke C, Willmes DM,
Bornstein SR, Jordan J, et al. Solute carrier
transporters as potential targets for the treatment of
metabolic disease, Pharm. Rev. 2020;72 (1): 343-79.
3. Guan Y, Hao CM. SIRT1 and Kidney Function.
Kidney Dis (Basel). 2016;1(4):258-65.
4. Webster AC, Nagler EV, Morton RL, Masson P.
Chronic kidney disease. Lancet. 2017;389 (10075):
1238-52.
5. Chen HH, Zhang YX, Lv JL, Liu YY, Guo JY, Zhao
L, et al. Role of sirtuins in metabolic disease-related
renal injury. Biomed Pharmacother.
2023;161:114417.
6. Li Z, Xu K, Zhang N, Amador G, Wang Y, Zhao S,
et al. Overexpressed SIRT6 attenuates cisplatin-
induced acute kidney injury by inhibiting ERK1/2
signaling. Kidney Int. 2018; 93 (4) : 881-92.
7. Bian C, Ren H. Sirtuin Family and Diabetic Kidney
Disease. Front Endocrinol (Lausanne).
2022;13:901066
8. Mortuza R, Feng B, Chakrabarti S. SIRT1 reduction
causes renal and retinal injury in diabetes through
endothelin 1 and transforming growth factor β1. J Cell
Mol Med. 2015;19(8):1857-67.
9. Wynn TA. Cellular and molecular mechanisms of
fibrosis. J Pathol. 2008;214:199-210.
10. Braga Gomes K, Fontana Rodrigues K, Paula
Fernandes A. The Role of Transforming Growth
Factor-Beta in Diabetic Nephropathy. Int J Med
Genet. 2014; 180270:1-6.
11. Ibrahim S, Rashed L. Estimation of transforming
growth factor-beta 1 as a marker of renal injury in type
II diabetes mellitus. Saudi Med J. 2007;28:519–23.
12. Rahimi G, Heydari S, Rahimi B, Abedpoor N,
Niktab I, Safaeinejad Z, et al. A combination of herbal
compound (SPTC) along with exercise or metformin
more efficiently alleviated diabetic complications
through down-regulation of stress oxidative pathway
upon activating Nrf2-Keap1 axis in AGE rich diet-
induced type 2 diabetic mice. Nutr Metab (Lond).
2021;18(1):14.
13. Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L,
Fuhrmann-Stroissnigg H, Xu M, et al. Fisetin is a
senotherapeutic that extends health and lifespan.
EBioMedicine. 2018 Oct;36:18-28
14. Grynkiewicz G, Demchuk OM. New Perspectives
for Fisetin. Front Chem. 2019;7:697.
15. Zou TF, Liu ZG, Cao PC, Zheng SH, Guo WT,
Wang TX, et al. Fisetin treatment alleviates kidney
injury in mice with diabetes-exacerbated
atherosclerosis through inhibiting CD36/fibrosis
pathway. Acta Pharmacol Sin. 2023;44(10):2065-74.
16. Fan R, Kong J, Zhang J, Zhu L. Exercise as a
therapeutic approach to alleviate diabetic kidney
disease: mechanisms, clinical evidence and potential
exercise prescriptions. Front Med (Lausanne).
2024;11:1471642.
17. Khoramipour K, Hekmatikar AA, Sotvan H. An
overview of Fatmax and MFO in exercise. Razi J.
Med. Sci. 2020;27:49–59.
18. Coates AM, Joyner MJ, Little JP, Jones AM, Gibala
MJ. A Perspective on High-Intensity Interval Training
for Performance and Health. Sports Med.
2023;53(Suppl 1):85-96.
19. Jabardo-Camprubí G, Donat-Roca R, Sitjà-Rabert
M, Milà-Villarroel R, Bort-Roig J. Drop-out ratio
between moderate to high-intensity physical exercise
treatment by patients with, or at risk of, type 2 diabetes
mellitus: A systematic review and meta-analysis.
Physiol Behav. 2020;215:112786.
20. Zheng L, Qin R, Rao Z, Xiao W. High-intensity
interval training induces renal injury and fibrosis in
type 2 diabetic mice. Life Sci. 2023;324:121740.
21. Lora-Pozo I, Lucena-Anton D, Salazar A, Galán-
Mercant A, Moral-Munoz JA. Anthropometric,
Cardiopulmonary and Metabolic Benefits of the High-
Intensity Interval Training Versus Moderate, Low-
Intensity or Control for Type 2 Diabetes: Systematic
Review and Meta-Analysis. Int J Environ Res Public
Health. 2019;16(22):4524.
22. Monno I, Ogura Y, Xu J, Koya D, Kitada M.
Exercise Ameliorates Diabetic Kidney Disease in
Type 2 Diabetic Fatty Rats. Antioxidants (Basel).
2021;10(11):1754.
23. Haghparast Azad M, Niktab I, Dastjerdi S,
Abedpoor N, Rahimi G, Safaeinejad Z, et al. The
combination of endurance exercise and SGTC (Salvia-
Ginseng-Trigonella-Cinnamon) ameliorate
mitochondrial markers' overexpression with sufficient
ATP production in the skeletal muscle of mice fed
AGEs-rich high-fat diet. Nutr Metab. 2022;19(1):17.
24. Qian X, Lin S, Li J, Jia C, Luo Y, Fan R, et al. Fisetin
Ameliorates Diabetic Nephropathy‐Induced Podocyte
Injury by Modulating Nrf2/HO‐1/GPX4 Signaling
Pathway. eCAM 2023;2023(1):9331546.
25. Khoramipour K, Rajizadeh MA, Akbari Z, Arjmand
M. The Effect of High-Intensity Interval Training on
Type 2 Diabetic Muscle: A Metabolomics-based
Study. Heliyon. 2024;10(15):e34917.
26. Ren H, Shao Y, Wu C, Lv C, Zhou Y, Wang Q.
VASH-1 Regulates Oxidative Stress and Fibrosis in
Diabetic Kidney Disease via SIRT1/HIF1a and Tgfb1/
Smad3 Signaling Pathways. Front Mol Biosci. 2020;
7:137.
27. Sutariya B, Jhonsa D, Saraf MN. TGF-β: the
connecting link between nephropathy and fibrosis
Immunopharmacol. Immunotoxicol. 2016; 38 (1): 39-
49
28. Kanwar YS, Sun L, Xie P, Liu FY, Chen S. A
glimpse of various pathogenetic mechanisms of
diabetic nephropathy. Annu Rev Pathol. 2011;6:395-
423.
29. Maeda S, Koya D, Araki S-I, Babazono T, Umezono
T, Toyoda M, et al. Association Between Single
Nucleotide Polymorphisms Within Genes Encoding
Sirtuin Families and Diabetic Nephropathy in
Japanese Subjects With Type 2 Diabetes. Clin Exp
Nephrol. 2011;15:381–90
30. Ren Q, Tao S, Guo F, Wang B, Yang L, Ma L, et al.
Natural flavonol fisetin attenuated hyperuricemic
nephropathy via inhibiting IL-6/JAK2/STAT3 and
TGF-β/SMAD3 signaling. Phytomedicine.
2021;87:153552.
31. Hussein MM, Mahfouz MK. Effect of resveratrol
and rosuvastatin on experimental diabetic
nephropathy in rats. Biomed Pharmacother.
2016;82:685-92.
32. Singh, S, Singh, AK, Garg, G, Rizvi, SI. Fisetin as a
caloric restriction mimetic protects rat brain against
aging induced oxidative stress, apoptosis and
neurodegeneration. Life Sci. 2018;193: 171-9.
33. Iside C, Scafuro M, Nebbioso A, Altucci L. SIRT1
Activation by Natural Phytochemicals: An Overview.
Front Pharmacol. 2020;11:1225.
34. Zhou Z, Ying C, Zhou X, Shi Y, Xu J, Zhu Y, et al.
Aerobic exercise training alleviates renal injury in
db/db mice through inhibiting Nox4-mediated NLRP3
inflammasome activation. Exp Gerontol.
2022;168:111934.
35. Saberi S, Askaripour M, Khaksari M, Amin
Rajizadeh M, Abbas Bejeshk M, Akhbari M, et al.
Exercise training improves diabetic renal injury byreducing fetuin-A, oxidative stress and inflammation
in type 2 diabetic rats. Heliyon. 2024;10(6):e27749.
36. Sun XJ, Feng WL, Hou N, Li N, Jiang WL. Effects
of aerobic exercise and resveratrol on the expressions
of JAK2 and TGF-β1 in renal tissue of type 2 diabetes
rats. Zhongguo Ying Yong Sheng Li Xue Za
Zhi.2020; 36 (3):202-06.
37. Faramarziyan N, Salesi M, Rezaei R, Kooshki
Jahromi M. Effects of Six Weeks High-Intensity
Interval Training on TGF-b1 and SMAD7 Genes
Expression in the Kidney Tissue of Elderly Diabetic
Male Wistar Rats. JSSU. 2023; 30 (12) :6185-98
38. Li RY, Guo L. Exercise in Diabetic Nephropathy:
Protective Effects and Molecular Mechanism. Int J
Mol Sci. 2024;25(7):3605.
39. Amaral LSB, Souza CS, Lima HN, Soares TJ.
Influence of exercise training on diabetic kidney
disease: A brief physiological approach. Exp Biol
Med (Maywood). 2020 245(13):1142-54.
40. Costanti-Nascimento AC, Brelaz-Abreu L,
Bragança-Jardim, E, Pereira WO, Camara, NOS,
Amano MT. Physical exercise as a friend not a foe in
acute kidney diseases through immune system
modulation. Front. Immunol. 2023;14: 1212163.
41. Yang L, Li DX, Cao BQ, Liu SJ, Xu DH, Zhu XY,
et al. Exercise training ameliorates early diabetic
kidney injury by regulating the H2 S/SIRT1/p53
pathway. FASEB J. 2021;35(9):e21823.
42. Mohsenzadeh M, Aghaei F, Nameni F. The effect of
high intensity interval training on SIRT1 and PGC1-α
gene expression in soleus muscle of type 2 diabetes in
male rats. Med J Tabriz Uni Med Sciences Health
Services. 2020; 42(4):447-455.
43. Liu H, Kao HH, Wu CH. Exercise training
upregulates SIRT1 to attenuate inflammation and
metabolic dysfunction in kidney and liver of diabetic
db/db mice. Nutr Metab. 2019; 16:22–32
44. Amaral L, Silva FA, Correia VB, Andrade CE, Dutra
BA, Oliveira MV, et al. Beneficial effects of previous
exercise training on renal changes in streptozotocin-
induced diabetic female rats. Exp Biol Med. 2016;
241:437–4.